<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04890769</url>
  </required_header>
  <id_info>
    <org_study_id>0007-P--047</org_study_id>
    <nct_id>NCT04890769</nct_id>
  </id_info>
  <brief_title>Clinical Study of Moisture Sensor Dressing Used for Exuding Wounds</brief_title>
  <official_title>Post Market Clinical Follow-up (PMCF) Study for DryMax Sensor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fredrik Iredahl</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Primary Health Care Center, Department of Health Medicine and Caring Sciences, Linköping University, Linköping, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vårdcentralen Åby</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational prospective study of the clinical use of a wound dressing with a moisture&#xD;
      sensor for use on exuding wounds.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The PMCF study will be performed as a prospective and open study of a wound dressing with a&#xD;
      moisture sensor on exuding wounds.&#xD;
&#xD;
      Using DryMax Sensor and the display indication - advisory only - might influence the&#xD;
      clinician's workflow and the patient's engagement in their care. The PMCF study aims to study&#xD;
      the use of the sensor in the clinical procedure of dressing changes in one or more healthcare&#xD;
      settings. To study how the new product is received, and how it is used in the workflow,&#xD;
      related to its clinical performance.&#xD;
&#xD;
      Furthermore, the aim is to gather safety-related clinical data for common harms within&#xD;
      exudate management.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 21, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Questionnaire regarding workflow of the clinical procedure for dressing change</measure>
    <time_frame>Enrollment to study completion (4 weeks)</time_frame>
    <description>Yes/no questions and questions with multiple choices</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Questionnaire regarding the satisfaction using the device</measure>
    <time_frame>Through study completion, up to 4 weeks</time_frame>
    <description>Scale 1-5 where 1= low, 5 = good</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Registration of device deficiencies</measure>
    <time_frame>Enrollment to study completion (4 weeks)</time_frame>
    <description>Type of device deficiency</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Registration of device deficiencies</measure>
    <time_frame>Enrollment to study completion (4 weeks)</time_frame>
    <description>Severity scale 1-3, 1=low, 3=high</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of days between visits</measure>
    <time_frame>Enrollment to study completion (4 weeks)</time_frame>
    <description>Dressing change frequency</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight of dressing after use using a balance</measure>
    <time_frame>Enrollment to study completion (4 weeks)</time_frame>
    <description>Utilisation of dressings capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Registration of time for display activation</measure>
    <time_frame>Enrollment to study completion (4 weeks)</time_frame>
    <description>Time for display activation - hours since application [h]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire regarding leakage, strike-through, exudate viscosity</measure>
    <time_frame>Enrollment to study completion (4 weeks)</time_frame>
    <description>Yes/no questions and questions with multiple choices</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire regarding wound status</measure>
    <time_frame>Enrollment to study completion (4 weeks)</time_frame>
    <description>Questions with multiple choices</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of wound size with a ruler</measure>
    <time_frame>Enrollment to study completion (4 weeks)</time_frame>
    <description>Wound size progression</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Exuding Wounds</condition>
  <condition>Ulcer, Leg</condition>
  <condition>Wound</condition>
  <arm_group>
    <arm_group_label>Participants</arm_group_label>
    <description>Patients with exuding wounds</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Moisture sensor wound dressing</intervention_name>
    <description>Clinical procedure for change of wound dressing</description>
    <arm_group_label>Participants</arm_group_label>
    <other_name>DryMax Sensor</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from primary health care&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  male or female, ≥18 years&#xD;
&#xD;
          -  presence of an exuding wound, according to the clinician's assessment&#xD;
&#xD;
          -  the wound is deemed suitable for treatment with DryMax Sensor&#xD;
&#xD;
          -  an appropriate dressing size is available to be used according to the size of the&#xD;
             wound&#xD;
&#xD;
          -  the participant has given a written informed consent to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  known pregnancy at the inclusion visit&#xD;
&#xD;
          -  known or suspected hypersensitivity to the DryMax Sensor or its components&#xD;
&#xD;
          -  mental inability, reluctance or language difficulties that cause difficulties in&#xD;
             understanding the meaning of participating in the study&#xD;
&#xD;
          -  ongoing treatment with systemic antibiotics&#xD;
&#xD;
          -  illness or treatment of an indication other than the wound and which, according to the&#xD;
             study personnel, can affect the wound treatment, the study, and/or the dressing.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fredrik Iredahl, MD. PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Linkoeping University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jenny Sandh, Msc.</last_name>
    <phone>+46(0)494-779950</phone>
    <email>jenny.sandh@absorbest.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fredrik Iredahl, MD. PhD.</last_name>
    <phone>+46(0)10-105 93 10</phone>
    <email>fredrik.iredahl@liu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Primary Health Care Center in Österlötland</name>
      <address>
        <city>Linköping</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Friberg, RN</last_name>
      <phone>+46(0)10-103 05 06</phone>
      <email>Eva.friberg@regionostergotland.se</email>
    </contact>
    <investigator>
      <last_name>Fredrik Iredahl, MD. PhD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 26, 2021</study_first_submitted>
  <study_first_submitted_qc>May 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Vårdcentralen Åby</investigator_affiliation>
    <investigator_full_name>Fredrik Iredahl</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be analyzed and published on a group level.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

